Trifecta Capital Advisors, LLC Fulgent Genetics, Inc. Transaction History
Trifecta Capital Advisors, LLC
- $452 Billion
- Q2 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 475 shares of FLGT stock, worth $10,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
475
Previous 475
-0.0%
Holding current value
$10,872
Previous $10.3 Million
9.58%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FLGT
# of Institutions
195Shares Held
15.3MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$89.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$32.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.22MShares$27.8 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$21.9 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$19.1 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $693M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...